Healthcare Professionals
Transforming MIGS in More Ways Than One
iStent inject® represents the next generation of Glaukos trabecular micro-bypass technology, which has been proven safe and effective in hundreds of thousands of eyes worldwide. iStent inject® creates two patent bypass pathways through the trabecular meshwork, resulting in multi-directional flow through Schlemm’s canal, and is advancing the standard of care for glaucoma patients.
Learn MoreA Breakthrough for Glaucoma Treatment
Discover how MIGS is helping eye care professionals and patients effectively manage like never before.
Learn MoreTwo Outflow Pathways. One New Standard.
Learn how iStent inject®, when used in conjunction with cataract surgery, is transforming the treatment of glaucoma.
Learn MoreMicro Stents. Macro Efficacy.
See the latest clinical data around iStent inject® patient outcomes.
Learn MoreOur Comprehensive Support. Your Uncompromising Patient Care.
Integrating iStent inject® into your practice helps you expand care, and provide a wider range of benefits to many of your patients. As a trusted industry leader—and the corporate founder of MIGS—we have the experience, tools, and training to make integration easy.
Learn MoreCommitment to Eye Care Professionals
Join us at one of our upcoming events and discover the latest technology and surgical options used to lower intraocular pressure in glaucoma patients.
Learn MoreAs a service to Our Customers, Glaukos Provides a Reimbursement & Billing Guide
ReimbursementLooking for more information on iStent inject®?
We’re here to answer questions and provide any additional information you may need.
Contact Us